Herbal dietary supplement recalled for undeclared drug ingredient
Sustain Herbal Dietary Supplement is being recalled nationwide for containing undeclared tadalafil, a pharmaceutical ingredient. The product was marketed as a dietary supplement but contains an unapproved drug.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This FDA Class I recall involves an unapproved drug product containing an undeclared pharmaceutical ingredient. The presence of tadalafil in a product marketed as a dietary supplement poses serious safety risks, justifying the Class I classification and Severe severity designation.
Plain-English summary
Sustain Herbal Dietary Supplement, packaged in 10 capsules per box and distributed by VSD Productions, Inc. (Las Vegas, Nevada), is being recalled due to the presence of undeclared tadalafil. The FDA classified this as a Class I recall.
Tadalafil is a pharmaceutical ingredient found in FDA-approved prescription medications for male sexual enhancement. The product was marketed as an herbal dietary supplement, but FDA analysis found it contained tadalafil without disclosure. This makes the product an unapproved drug.
The recalled product includes 7,000 boxes with the following lot numbers: BTH:230551 (expiration date 12.05.2026) and BTH:230571 (expiration date 14.05.2026). Distribution was nationwide within the United States.
Consumers who have purchased this product should stop using it immediately. Return the product to the place of purchase or dispose of it safely. If you have concerns, contact your healthcare provider.
The recalled product
- Product
- Sustain Herbal Dietary Supplement, packaged in 10 capsules per box, Distributed by VSD Productions, Inc. Las Vegas, Nevada
- Manufacturer
- Today The World
- Category
- Drug — Herbal Dietary Supplement
- Hazard
- undeclared-tadalafil
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: BTH:230551
- Exp. Date 12.05.2026
- BTH:230571
- Exp. Date 14.05.2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27